Mei, Xiaodong
Anhui Provincial Hospital
2 papers on CoChatORCID 0000-0002-7629-9200
Most cited papers
- Verified
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)
Yang, Y., Wang, Z., Fang, J., Yu, Q., Han, B., Cang, S., Chen, G., Mei, X., Yang, Z., Ma, R., et al. (2020) · Journal of Thoracic Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 390
- Verified
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
Xiong, A., Wang, L., Chen, J., Wu, L., Liu, B., Yao, J., Zhong, H., Li, J., Cheng, Y., Sun, Y., et al. (2025) · The Lancet
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 173
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free